VHL and renal cell carcinoma: The design of this cell-based screen included the following important features: 1) It employed a VHL-mutant RCC tumor cell line and an isogenic control reconstituted with VHL. 2) The screen (involving mutant cells) and the counterscreen (with the reconstituted cells) were carried out simultaneously.